| 1 | 13NH3 PET/CT scan | - | - | - | - | 1件: 84 84 |
| 2 | 18F-DOPA PET | - | - | - | - | 1件: 6 6 |
| 3 | 18FDG PET/CT scan | - | - | - | - | 1件: 84 84 |
| 4 | 68Ga-DOTATATE PET/CT | 2件: Dotatate Dotatate,
Dotatate gallium Ga-68 | - | - | - | 1件: 84 84 |
| 5 | [18F] LBT-999 PET | - | - | - | - | 1件: 6 6 |
| 6 | [18F]-FLT-PET/CT scans | - | - | - | - | 1件: 34 34 |
| 7 | [18F]DPA-714 PET | - | - | - | - | 1件: 2 2 |
| 8 | [18F]DPA-714 PET scan | - | - | - | - | 1件: 6 6 |
| 9 | [18F]FDOPA PET/CT | - | - | - | - | 1件: 6 6 |
| 10 | [18F]Florbetapir PET imaging | - | - | - | - | 1件: 13 13 |
| 11 | [18F]FPEB PET imaging | - | - | - | - | 1件: 206 206 |
| 12 | [68Ga]Ga-PentixaFor PET/CT | - | - | - | - | 1件: 84 84 |
| 13 | [C11]PK-1195 PET scan | - | - | - | - | 1件: 13 13 |
| 14 | [Zr-89]Oxine-labeled leukocytes PET/MRI | 1件: Oxyquinoline Oxyquinoline | 1件: D05321
D05321
| - | - | 1件: 13 13 |
| 15 | DPA-714 PET/MRI | - | - | - | - | 1件: 13 13 |
| 16 | DPA-714-PET/MRI | - | - | - | - | 1件: 6 6 |
| 17 | ESR-specific PET scan | - | - | - | - | 1件: 86 86 |
| 18 | GE180 PET Scan | - | - | - | - | 1件: 6 6 |
| 19 | PET | - | - | - | - | 1件: 6 6 |
| 20 | PET with 11C-Flumazenil | 1件: Flumazenil Flumazenil | 1件: D00697
D00697
| 16件: GABRA1 GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 13 13 |
| 21 | PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714 | - | - | - | - | 1件: 85 85 |
| 22 | PET10 | - | - | - | - | 1件: 41 41 |
| 23 | PET3 | - | - | - | - | 1件: 41 41 |
| 24 | Petrolatum | 1件: Petrolatum Petrolatum | 1件: D05331
D05331
(Name: Petrolatum) | - | - | 1件: 158 158 |